MARKET OUTLOOK Pancreatic cancer is a life-threatening disease with a...
MARKET OUTLOOK Pancreatic cancer is a life-threatening disease with a survival rate of less than 10% and with no improvements in the last 40 years. Owing to the lack of......
No disease-modifying therapies are approved to treat primary Sjögren’s...
No disease-modifying therapies are approved to treat primary Sjögren’s syndrome (pSS), a progressive, autoimmune disease characterized b...
Over the past two decades, in response to mounting failures, clinical trials...
Over the past two decades, in response to mounting failures, clinical trials of disease-modifying therapies (DMTs) in Alzheimer’s disease...
MARKET OUTLOOK Renal inflammation associated with systemic lupus...
MARKET OUTLOOK Renal inflammation associated with systemic lupus erythematosus (SLE), also known as lupus nephritis (...
The management of pediatric patients with moderate to severe atopic dermatitis...
The management of pediatric patients with moderate to severe atopic dermatitis (AD) is poised for transformation. Sanofi/Regeneron’s Dupixent, on the...
DED is one of the most common ocular conditions in the United States and...
DED is one of the most common ocular conditions in the United States and Europe. Inflammation plays a prominent role in the pathogenesis of ...
Insomnia is a highly prevalent sleep disorder characterized by daytime...
Insomnia is a highly prevalent sleep disorder characterized by daytime dysfunction resulting from sleep problems. The treatment of insomnia is highly individualized, and physicians consider multi......
MARKET OUTLOOK Several effective anti-inflammatory agents and...
MARKET OUTLOOK Several effective anti-inflammatory agents and bronchodilators are available for controlling patients’ mild or moderate asthma. However, despite the...
Coming Soon – October 2019 MARKET OUTLOOK Rituximab-based...
Coming Soon – October 2019 MARKET OUTLOOK Rituximab-based chemoimmunotherapy regimens (e.g...
MARKET OUTLOOK Although TNF-alpha inhibitors remain the preferred choice for...
MARKET OUTLOOK Although TNF-alpha inhibitors remain the preferred choice for psoriatic arthritis (...
MARKET OUTLOOK Rheumatoid arthritis (RA) patients refractory to one or more...
MARKET OUTLOOK Rheumatoid arthritis (RA) patients refractory to one or more TNF-&alp......
MARKET OUTLOOK Dyslipidemia is an important modifiable risk factor for CV...
MARKET OUTLOOK Dyslipidemia is an important modifiable risk factor for CV disease and is primarily managed with statin therapy. Based......
MARKET OUTLOOK Multiple myeloma is an incurable hematological malignancy...
MARKET OUTLOOK Multiple myeloma is an incurable hematological malignancy despite the availability of several treatment options. Resistance to therapy is the primary trea......
Childhood absence epilepsy (CAE) is characterized by frequent and brief...
Childhood absence epilepsy (CAE) is characterized by frequent and brief absence seizures in children aged 4-12 and is diagnosed in approximately 10......
MARKET OUTLOOK Treatment of moderate to severe Crohn’s disease (CD)...
MARKET OUTLOOK Treatment of moderate to severe Crohn’s disease (CD) typically begins with safe, albeit often less-efficacious...
MARKET OUTLOOK Tumor necrosis factor-alpha (TNF-α) inhibitors (AbbVie’s...
MARKET OUTLOOK Tumor necrosis factor-alpha (TNF-α) inhibitors (AbbVie’s Humira, Amgen’s Enbrel, Janssen&...
MARKET OUTLOOK With a drug-treated population of more than 4 million people...
MARKET OUTLOOK With a drug-treated population of more than 4 million people in the United States and EU5, th......
Several antipsychotic therapies are available for the treatment of...
Several antipsychotic therapies are available for the treatment of schizophrenia and primarily control the positive symptoms of the disease. However, given that a sizable portion of schizophreni......
MARKET OUTLOOK The moderate to severe ulcerative colitis (UC) therapy market...
MARKET OUTLOOK The moderate to severe ulcerative colitis (UC) therapy market still offers substantial opportunity for companies that can address the remaining unmet need......
Fibromyalgia is a chronic condition characterized by pain and tenderness. The...
Fibromyalgia is a chronic condition characterized by pain and tenderness. The primary goal of treatment is to reduce pain, and there are multiple well-established treatment options available, man......
